362P Dose reductions due to treatment-related side effects and survival outcomes in breast cancer patients treated with CDK4/6 Inhibitors
| Autor: | Tolunay, P. Kubilay, Inci, B. Kurt, Usta, S., Topkac, A., Karabuga, B., Aydemir, E., Karacin, C., Ates, O. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S369-S369 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|